
Active Implants
Founded Year
2004Stage
Debt - IX | AliveTotal Raised
$142.1MLast Raised
$5.5M | 4 mos agoAbout Active Implants
Active Implants develops orthopedic implant solutions that complement the natural biomechanics of the musculoskeletal system, allowing patients to maintain or return to an active lifestyle.
Active Implants Headquarter Location
6060 Primacy Parkway Suite 460
Memphis, Tennessee, 38119,
United States
901-762-0352
Research containing Active Implants
Get data-driven expert analysis from the CB Insights Intelligence Unit.
CB Insights Intelligence Analysts have mentioned Active Implants in 1 CB Insights research brief, most recently on Mar 26, 2020.

Mar 26, 2020
40+ ‘Breakthrough’ Medical Device StartupsExpert Collections containing Active Implants
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Active Implants is included in 2 Expert Collections, including Medical Devices.
Medical Devices
8,472 items
Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.
Health IT
7,900 items
Active Implants Patents
Active Implants has filed 40 patents.
The 3 most popular patent topics include:
- Implants (medicine)
- Orthopedic surgical procedures
- Prosthetics
Application Date | Grant Date | Title | Related Topics | Status |
---|---|---|---|---|
5/6/2019 | 9/28/2021 | Orthopedic surgical procedures, Finite element method, Skeletal system, Numerical differential equations, Memory processes | Grant |
Application Date | 5/6/2019 |
---|---|
Grant Date | 9/28/2021 |
Title | |
Related Topics | Orthopedic surgical procedures, Finite element method, Skeletal system, Numerical differential equations, Memory processes |
Status | Grant |
Latest Active Implants News
Nov 30, 2021
News provided by Share this article Share this article The U.S. medical device outsourcing market size is expected to reach USD 46.2 billion by 2028 and is expected to expand at a CAGR of 10.3% from 2021 to 2028 The growing geriatric population, rising surgical procedures, and increasing demand for cost curbing tools are some key growth drivers for the U.S. market. The medical device industry has become competitive and categories such as coronary stents, orthopedic devices, and wound care are moving towards maturity. As high-impact scientific innovation in the above categories is difficult to identify, smaller companies are gaining market share by offering low prices and introducing innovative business models. Due to the convergence of mounting challenges and changing market dynamics, many medical device manufacturers have opted for outsourcing business models to reduce cost, manage business risks, and improve service delivery. All the aforementioned facts are hence expected to propel the market growth over the forecast period. The development of medical devices and supplies required in assisting COVID patients and medical professionals is increasing. The government authorities have escalated funds for the research & development of essential devices, thus increasing the demand in the U.S. market. Major companies have solely relied on contract manufacturers to ramp up the production of COVID-19-related medical components, such as test kits, ventilators, and respirators. The major reasons for outsourcing amid the COVID crisis include a streamlined supply chain, costing efficiencies, and logistical alignment. U.S. Medical Device Outsourcing Market Report Highlights Based on service, the contract manufacturing segment dominated the market with a share of 55.5% in 2020 owing to the growing trend of outsourcing by OEM to third-party manufacturers, especially in emerging countries Regulatory consulting services are projected to exhibit a significant growth rate over the forecast period. Complex regulatory requirements related to writing and submission of clinical study reports promote outsourcing of noncore regulatory functions, such as regulatory writing and publishing By application, class II medical devices held the largest share of 67.2% in 2020 and are expected to dominate the U.S. market throughout the forecast period Mergers and acquisitions and capacity expansion are a few of the common strategies adopted by market players to gain a competitive edge in the market In February 2020, Teleflex acquired HPC Medical Products (HPC), a company involved in medical tubing and wire components. The acquisition will help Teleflex to strengthen its catheter contract manufacturing capabilities Key Topics Covered: Chapter 2 Executive Summary 3.1 Market Dynamic
Active Implants Web Traffic
Active Implants Rank
When was Active Implants founded?
Active Implants was founded in 2004.
Where is Active Implants's headquarters?
Active Implants's headquarters is located at 6060 Primacy Parkway, Memphis.
What is Active Implants's latest funding round?
Active Implants's latest funding round is Debt - IX.
How much did Active Implants raise?
Active Implants raised a total of $142.1M.
Who are the investors of Active Implants?
Investors of Active Implants include LS Health Science Partners, River Street Management, View Capital Advisors, Kemmons Wilson Companies, DISCure and 3 more.
Who are Active Implants's competitors?
Competitors of Active Implants include Wright Medical Group, Cagenix, Powervision, Paragon Medical, Netpulse and 15 more.
You May Also Like
Intelligent Orthopaedics, the designers of STORM (The staffordshire orthopaedic reduction machine) for the reduction of tibial fractures and IOS the flexible, single use fixator

BioHorizons is a provider in advanced dental implant technologies and tissue regeneration products in the dental implant industry. The company, based in Birmingham, Alabama, offers a broad spectrum of products for the replacement of missing teeth including dental implants, restorative and laboratory components, soft and hard tissue biologic products, and surgical planning software. BioHorizons' unique dental implant designs are recognized for intuitive design, excellent primary stability, and high-end, esthetic outcomes through the use of BioHorizons' Laser-Lok microchannel surface technology. Laser-Lok has been shown to uniquely achieve both bone and soft tissue attachment for long-term tissue maintenance. The company has six international subsidiaries and more than 50 distributors around the world.
Biophan is dedicated to providing technologies that offer innovative andcompetitive advantages to the medical device industry. The Company ishelping to commercialize the Myotech Circulatory Support System, which has potential to improve the treatment of acute heart failure.Biophan Technologies, Inc. holds a 68% interest in Myotech. Biophan istraded on the OTC market under the symbol BIPH, and is also listed on theFrankfurt Stock Exchange under the symbol BTN.
iBalance, Inc. is developing an improved method for completing an orthopedic surgical procedure called high tibial osteotomy. The company aims to provide the surgical tools and implant for this knee malalignment corrective surgery.

Cagenix develops and researches new devices for dental implants. The company's main focus is on providing superstructures for multiple dental implants that is used to restore chewing function and aesthetics for patients.
SAMO is present in the hospitals and in the operating rooms and for forty years it has been focusing on developing joint reconstruction implants and internal fixation products. Meanwhile the company aims to offer steadily he best technologies and service to the professionals who operate and implant the company's products in the field.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.